跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
FUROSEMIDE INJECTION USP
Authorized
STANDARD
FUROSEMIDE INJECTION USP
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b0f5ea9790da2232
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
b0f5ea9790da2232
Drug Approval Canada Name
FUROSEMIDE INJECTION USP
Product Name
FUROSEMIDE INJECTION USP
Status
Marketed
Status Date
2024-01-23
Original Market Date
2024-01-23
Din
02527502
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription
Ahfs
40:28.08
Atc Original
C03CA01 FUROSEMIDE
Atc Name
c 03 ca 01
Aig Number
0101944003
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
FUROSEMIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b0f5ea9790da2232
Type
Standard
Back to Health Canada Approvals
FUROSEMIDE INJECTION USP - Health Canada Drug Approval Details